Clinical trial
Study of UC-781 Vaginal Microbicide
NCT00132444 · CONRAD, Other · Completed
Key facts
| NCT number | NCT00132444 |
|---|---|
| Title | Study of UC-781 Vaginal Microbicide |
| Official title | Phase I Study of the Safety and Acceptability of UC-781 Topical Vaginal Microbicide in Heterosexual Women and Their Male Partners |
| Lead sponsor | CONRAD, Other |
| Collaborators | Emory University Centers for Disease Control and Prevention U.S. Fed |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | topical vaginal application of UC-781 gel |
| Enrollment | 90 |
| Start date | Oct 1, 2005 |
| Primary completion | Dec 1, 2008 |
| Completion | Dec 1, 2008 |
| First posted | Aug 22, 2005 |
| Last update posted | Jan 7, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: